Showing results (201-210 of 212) with videos related to

Sort By:
Pageof 22
Pain Reports|May 13, 2021
Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendationsJennifer S Gewandter, Robert H Dworkin, Dennis C Turk, et al.
The Lancet. Neurology|November 19, 2020
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension studyDavid Adams, Michael Polydefkis, Alejandra González-Duarte, et al.
Pain|June 11, 2020
Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerationsShannon M Smith, Robert H Dworkin, Dennis C Turk, et al.
Pain|September 12, 2021
Benefit-risk assessment and reporting in clinical trials of chronic pain treatments: IMMPACT recommendationsBethea A Kleykamp, Robert H Dworkin, Dennis C Turk, et al.
Pain|May 29, 2014
Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendationsJennifer S Gewandter, Robert H Dworkin, Dennis C Turk, et al.
Pain|April 17, 2021
Research approaches for evaluating opioid sparing in clinical trials of acute and chronic pain treatments: Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials recommendationsJennifer S Gewandter, Shannon M Smith, Robert H Dworkin, et al.
Pain|September 25, 2012
Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendationsSandra D Comer, James P Zacny, Robert H Dworkin, et al.
Pain|October 24, 2013
Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendationsAlec B O'Connor, Dennis C Turk, Robert H Dworkin, et al.
Pain|April 13, 2012
Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendationsRobert H Dworkin, Dennis C Turk, Sarah Peirce-Sandner, et al.
The New England Journal of Medicine|July 5, 2018
Inotersen Treatment for Patients with Hereditary Transthyretin AmyloidosisMerrill D Benson, Márcia Waddington-Cruz, John L Berk, et al.
Pageof 22